• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Covidien

Covidien

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Global Nuclear Medicine Market Worth USD 19.4 Billion by 2020 - Analysis, Technologies & Forecasts Report 2015-2020 - Vendors: Covidien , GE Healthcare, Nordion - Research and Markets

    Global Nuclear Medicine Market Worth USD 19.4 Billion by 2020 - Analysis, Technologies & Forecasts Report 2015-2020 - Vendors: Covidien , GE Healthcare, Nordion - Research and Markets

  2. European Market Report for Port Needles 2017 - MedCore - Research and Markets

    European Market Report for Port Needles 2017 - MedCore - Research and Markets

  3. European Product Portfolio for Vascular Access Devices and Accessories 2017 - MedFolio - Research and Markets

    European Product Portfolio for Vascular Access Devices and Accessories 2017 - MedFolio - Research and Markets

  4. Covidien's Wide-Moat Device Business Positioned Well for Long-Term Growth

    R&D investments and a narrowed focus have widened the firm's competitive advantages.

  5. Covidien's Mallinckrodt Spin-Off Faces Challenging Environment

    Mallinckrodt's lack of scale and weak branded business keep it from earning a moat.

  6. The Reluctant Bulls of 2014

    After a few fits and starts, Tyco is now set to trade under three separate tickers starting July 2. Tyco International will retain the TYC ticker, Tyco Electronics will assume the TEL ticker, and Covidien , the health-care concern, will trade as COV . We'll have a separate analyst covering each; ...

  7. Super-Wide Moat in the Making at Medtronic

    The device maker's planned acquisition of Covidien will make it a force to be reckoned with.

  8. Nominees for 2014 International-Stock Manager of the Year

    A tough year for foreign markets and currencies yields a compact field.

  9. Nominees for 2014 International-Stock Manager of the Year

    A tough year for foreign markets and currencies yields a compact field.

  10. Health Care: A Strong Run, but Some Stocks Still Look Undervalued

    While the sector looks slightly overvalued overall, we still see several stocks that offer attractive valuations across the different industries.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.